W. Sukeepaisarnjaroen

发表

VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial

A. Zhu, T. Yau, L. Rimassa, 2021, Annals of Oncology.

An enzyme-linked immunosorbent assay as screening tool for human intestinal capillariasis.

P. Intapan, W. Maleewong, N. Morakote, 2010, The Southeast Asian journal of tropical medicine and public health.

Comparison of adult somatic and excretory-secretory antigens in enzyme-linked immunosorbent assay for serodiagnosis of human infection with Fasciola gigantica.

C. Wongkham, P. Intapan, W. Maleewong, 1996, The Southeast Asian journal of tropical medicine and public health.